GILD

Gilead Sciences, Inc. News Headlines

$105.96
*  
0.03
0.03%
Get GILD Alerts
*Delayed - data as of Sep. 19, 2014  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

VIVUS and Auxilium Announce Stendra Label Expansion - Analyst Blog
9/19/2014 6:25:00 PM - Zacks.com

Bristol-Myers' (BMY) Yervoy Label Expanded in Canada - Analyst Blog
9/19/2014 5:40:00 PM - Zacks.com

Spectrum Pharmaceuticals Out-Licenses Products in China - Analyst Blog
9/19/2014 5:15:00 PM - Zacks.com

Bayer to Shed MaterialScience Business, Shares Rise - Analyst Blog
9/19/2014 5:10:00 PM - Zacks.com

Eli Lilly's Trulicity Approved by FDA for Type II Diabetes - Analyst Blog
9/19/2014 4:50:00 PM - Zacks.com

Is Merck KGaA on Track with its "Fit for 2018" Program? - Analyst Blog
9/19/2014 2:50:00 PM - Zacks.com

Dividend Aristocrats: Time to Buy AbbVie Inc Stock?
9/19/2014 12:32:06 PM - Motley Fool

Incyte: Increasing Sales, Deep Pipeline, Multiple Catalysts, With A Side Of M&A Chatter
9/19/2014 11:58:00 AM - Seeking Alpha

5 Things Gilead Sciences, Inc. Management Wants You to Know
9/19/2014 11:30:08 AM - Motley Fool

VIVUS Inc. (VVUS) Rises: Stock Adds 12.4% in Session - Tale of the Tape
9/19/2014 9:32:00 AM - Zacks.com

Gilead Emerging Market Agreement: Huge Win For Patients, Non-Event For Investors.
9/19/2014 9:26:00 AM - Seeking Alpha

Sector Update: Health-Care Shares Lower in Pre-Market Trade
9/19/2014 8:11:05 AM - MT Newswires

Sector Update: Health Care
9/19/2014 8:10:39 AM - MT Newswires

European Commission Grants Marketing Authorization To Gilead's Zydelig
9/19/2014 7:00:00 AM - RTT News

Sanofi & MyoKardia Ink Deal to Develop Cardiomyopathies - Analyst Blog
9/18/2014 5:35:00 PM - Zacks.com

Bayer/Orion Progress with Prostate Cancer Drug ODM-201 - Analyst Blog
9/18/2014 5:15:00 PM - Zacks.com

Alnylam (ALNY) to File Clinical Trial Application for ALN-CC5 - Analyst Blog
9/18/2014 5:10:00 PM - Zacks.com

Gilead Down on Weak Simtuzumab Data and Sovaldi News - Analyst Blog
9/18/2014 4:16:00 PM - Zacks.com

Gilead Science stumbles, but stays on its feet
9/18/2014 11:52:00 AM - Market Intelligence Center

Gilead: Still 50% Upside Left In The Stock
9/18/2014 11:12:00 AM - Seeking Alpha

Is It Time to Buy Dividend Stock Bristol-Myers Squibb Co?
9/18/2014 10:57:44 AM - Motley Fool

Gilead Sciences: The Recent Dip In Share Price Creates A Buying Opportunity
9/18/2014 10:55:00 AM - Seeking Alpha

ImmunoCellular Therapeutics (IMUC) Jumps: Stock Up 9% - Tale of the Tape
9/18/2014 9:58:00 AM - Zacks.com

Halozyme Therapeutics (HALO) Jumps: Stock Up 9.3% - Tale of the Tape
9/18/2014 9:39:00 AM - Zacks.com

Repros Therapeutics (RPRX) Crumbles: Stock Falls by 10.5% - Tale of the Tape
9/18/2014 8:51:00 AM - Zacks.com